Tag: excipients

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the...

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 5, 2025 to report its second quarter 2025 financial results and provide a corporate update.

Ampersand Capital Partners Invests in CurTec, a Global Leader in Pharma & Specialty Chemicals Bulk Packaging

Strategic partnership to accelerate U.S. growth, product innovation, and long-term value creation in life sciences supply chain. BOSTON and RIJEN, Netherlands, July 21, 2025 /PRNewswire/...

CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

SHANGHAI, July 21, 2025 /PRNewswire/ -- CPHI & PMEC China 2025 concluded in June with a record-breaking 109,056 attendees, underscoring strong demand within China's...

Female Muscle Growth: How CrazyBulk’s Natural Legal Steroids Are Reshaping Muscle Building Supplements For Bodybuilding Women

Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth.

Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth.

As consumer interest in the best activated charcoal grows, NativePath introduces a clean-label, high-purity formula derived from coconut shells to support bloating, gas, and digestive detox.

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsExcipients

Synology showcases the next generation DiskStation Manager and a full lineup of data management solutions at COMPUTEX 2026

Bell Announces Upsizing and Results of its Cash Tender Offers for Debt Securities

LONGi Showcases LONGi ONE at SNEC 2026, Advancing Native Solar-Plus-Storage Integration

Tag: excipients

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

Ampersand Capital Partners Invests in CurTec, a Global Leader in Pharma & Specialty Chemicals Bulk Packaging

CPHI & PMEC Shenzhen 2025: Unlocking New Opportunities in Asia and the Greater Bay Area

Female Muscle Growth: How CrazyBulk’s Natural Legal Steroids Are Reshaping Muscle Building Supplements For Bodybuilding Women

Microcrystalline Cellulose (MCC) Market worth $1.88 billion by 2030- Exclusive Report by MarketsandMarkets™

Microcrystalline Cellulose (MCC) Market worth $1.88 billion by 2030- Exclusive Report by MarketsandMarkets™

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico’s Life Sciences Market

LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico’s Life Sciences Market

LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico’s Life Sciences Market

LBB Specialties Expands Distribution Partnership with Clariant to Support Puerto Rico’s Life Sciences Market

NativePath Launches Most Effective Activated Charcoal Yet—1,000mg Coconut-Shell Formula for Daily Gut Health

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us